Sanofi takes its own drug pricing pledge, pointing to a decline in their aggregate net price
Sanofi CEO Sanofi Olivier Brandicourt (left), flanked by CFO Jerome Contamine, speaks during the presentation of the group’s 2016 results in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
